Pharmaceutical Technology, October 2014 Issue (PDF)

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-10-02-2014
Volume 38
Issue 10

Click the title above to open the Pharmaceutical Technology October 2014 issue in an interactive PDF format.

External Link - PharmTech_NA_Oct2014.pdf

Articles in this issue
Ross-856927-1416898025646.jpg
Ross Agitated Vessel Includes Silicone Heating Blankets
Analytical Method Comparability in Registration and Post-Approval Stages: A Risk-Based Approach
Analytical Method Comparability in Registration and Post-Approval Stages: A Risk-Based Approach
Wechsler_Jill-856790-1416898146268.jpg
Biopharma Manufacturers Respond to Ebola Crisis
Determining Facility Mold Infection
romacokilianktp-856928-1416898023256.jpg
Romaco Kilian's Tablet Press Introduces Continuous Weight Control
GEA-856930-1416898019279.jpg
GEA Pharma Systems Valves Contain Powders
figure1-856883-1417773790013.jpg
Packaging Addresses Cold-Chain Requirements
Fluorination Remains Key Challenge in API Synthesis
Fluorination Remains Key Challenge in API Synthesis
Fette-856929-1416898021360.jpg
Fette Tablet Press Designed for High Production
Marrying Big Data with Personalized Medicine
Marrying Big Data with Personalized Medicine
Morris_marilyn-856679-1416897342957.jpg
Bolstering Graduate Education and Research Programs
Solving Poor Solubility with Amorphous Solid Dispersions
Solving Poor Solubility with Amorphous Solid Dispersions
The Role of Normal Data Distribution in Pharmaceutical Development and Manufacturing
The Role of Normal Data Distribution in Pharmaceutical Development and Manufacturing
Milmo_Sean-856903-1416898033486.jpg
Harmonizing Marketing Approval of Generic Drugs in Europe
AlphaG-gd-858224-1416895790953.jpg
Meissner's Filtration System Allows Scalability
Recent Videos
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
DC skyline at night with view of the White House and the Washington Monument | Image Credit: © Jessica - stock.adobe.com
Behind the Headlines, Episode 18
Related Content
Thornhill, Ontario, Canada - October 31, 2020: LEO Pharma Canada sign outside their head office building in Thornhill, Ontario, Canada. LEO Pharma AS is a multinational Danish pharmaceutical company | Image Credit: © JHVEPhoto - stock.adobe.com.

LEO Pharma Takes Over Global Development of Spevigo for Rare Skin Disease GPP

Christopher Cole
July 14th 2025
Article

The IL-36 inhibitor is being explored for additional inflammatory skin conditions, aiming to expand treatment options for underserved patient groups.

Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries

Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries

Patrick Lavery
May 30th 2025
Podcast

In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.

Site Logo

Streamlined Product Development Leveraging Pharmaceutical Classification Models

Serán
July 11th 2025
Article
Site Logo

Transformations in Drug Development for Cell and Gene Therapies

PPD;Thermo Fisher Scientific
March 28th 2025
Podcast

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.

Brain Injury, Blood in Injured Brains (stroke, brain hemorrhage, intracerebral hemorrhage, subarachnoid hemorrhage, arteriovenous malformation, brain aneurysm rupture, traumatic brain injury) | Image Credit: © Arugula Pica - stock.adobe.com

Generative AI-Driven Collaboration to Research Treatments for Brain Hemorrhage Complications

Patrick Lavery
July 9th 2025
Article

Delayed cerebral ischemia is a leading complication in the severe form of stroke known as subarachnoid hemorrhage and can result in long-term neurological damage, disability, or death.

Pharmaceutical research and development in laboratory, with focus on medicine preparation, powder substances, and glass vials for drug formulation and testing | Image Credit: © felix_brönnimann - stock.adobe.com

Dosage Form Compounding in the Workplace Environment

Paul L. Pluta;Alan M. Mancini;Nishant B. Thakar;Varanya Chaiyaperm
July 8th 2025
Article

An ordered pharmaceutical compounding process for use in 503A pharmacies, 503B outsourcing facilities, pharmaceutical industry, and other applications.